New Key Statistics Module, Z-Score and F-Score
AMEX:PLX Key Ratios
Market Cap $ M | 82.55 |
Enterprise Value $ M | 64.27 |
P/E(ttm) | 56.50 |
PE Ratio without NRI | 56.50 |
Forward PE Ratio | -- |
Price/Book | 2.46 |
Price/Sales | 1.36 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 65.00 |
EPS (TTM) $ | 0.02 |
Beneish M-Score | -1.28 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 5.47 |
EV-to-EBITDA | 4.96 |
PEG | -- |
Shares Outstanding M | 73.05 |
Net Margin (%) | 12.69 |
Operating Margin % | 15.97 |
Pre-tax Margin (%) | 13.08 |
Quick Ratio | 1.12 |
Current Ratio | 1.54 |
ROA % (ttm) | 10.86 |
ROE % (ttm) | 41.07 |
ROIC % (ttm) | 33.60 |
Dividend Yield % | -- |
Altman Z-Score | -3.77 |
Piotroski F-Score | 6.00 |
Positive ROA | Y |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | N |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | Y |
PLX Number of Guru Trades
PLX Volume of Guru Trades
Gurus Latest Trades with AMEX:PLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:PLX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Protalix BioTherapeutics Inc Insider Transactions
No Available Data
News about AMEX:PLX
Total 0- 1